/Henry%20Schein%20Inc_%20sign%20outside%20office-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Valued at a market cap of $8.9 billion, Henry Schein, Inc. (HSIC) is a distributor of healthcare products and services, including vaccines, pharmaceuticals, financial services, and equipment. This New York-based company operates through two segments: Health Care Distribution and Technology and Value-Added Services.
Shares of this healthcare products maker have significantly underperformed the broader market over the past 52 weeks. HSIC has declined 8.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 28.3%. In 2024, shares of HSIC dipped 7.8%, compared to SPX’s 17.6% gain on a YTD basis.